The content is available as a PDF (424.3 KB).
letter . 2021 Mar 6:ciab214. doi: 10.1093/cid/ciab214
Impressive boosting of anti-S1/S2 IgG production in COVID-19-experienced patients after the first shot of the BNT162b2 mRNA COVID-19 Vaccine
Amedeo F Capetti
1,✉, Carlo A Stangalini
2, Fabio Borgonovo
1, Davide Mileto
3, Letizia Oreni
4, Gianfranco Dedivitiis
1, Angelica Lupo
4, Maria V Cossu
1, Lara Bilardo
2, Andrea Giacomelli
4, Massimo Galli
4, Giuliano Rizzardini
1,5
Amedeo F Capetti
1
1st Division of Infectious Diseases, ‘Luigi Sacco’ University Hospital, Milan, Italy
Find articles by Amedeo F Capetti
Carlo A Stangalini
2
‘San Giuseppe Moscati’ Foundation, Milan, Italy
Find articles by Carlo A Stangalini
Fabio Borgonovo
1
1st Division of Infectious Diseases, ‘Luigi Sacco’ University Hospital, Milan, Italy
Find articles by Fabio Borgonovo
Davide Mileto
3
Clinical Microbiology Unit, ‘Luigi Sacco’ University Hospital, Milan, Italy
Find articles by Davide Mileto
Letizia Oreni
4
Università di Milano, Dipartimento di Scienze Biomediche e Clinche L. Sacco, Milan, Italy
Find articles by Letizia Oreni
Gianfranco Dedivitiis
1
1st Division of Infectious Diseases, ‘Luigi Sacco’ University Hospital, Milan, Italy
Find articles by Gianfranco Dedivitiis
Angelica Lupo
4
Università di Milano, Dipartimento di Scienze Biomediche e Clinche L. Sacco, Milan, Italy
Find articles by Angelica Lupo
Maria V Cossu
1
1st Division of Infectious Diseases, ‘Luigi Sacco’ University Hospital, Milan, Italy
Find articles by Maria V Cossu
Andrea Giacomelli
4
Università di Milano, Dipartimento di Scienze Biomediche e Clinche L. Sacco, Milan, Italy
Find articles by Andrea Giacomelli
Massimo Galli
4
Università di Milano, Dipartimento di Scienze Biomediche e Clinche L. Sacco, Milan, Italy
Find articles by Massimo Galli
Giuliano Rizzardini
1
1st Division of Infectious Diseases, ‘Luigi Sacco’ University Hospital, Milan, Italy
5
School of Medicine, University of the Witwatersrand, Johannesburg, South Africa
Find articles by Giuliano Rizzardini
1
1st Division of Infectious Diseases, ‘Luigi Sacco’ University Hospital, Milan, Italy
2
‘San Giuseppe Moscati’ Foundation, Milan, Italy
3
Clinical Microbiology Unit, ‘Luigi Sacco’ University Hospital, Milan, Italy
4
Università di Milano, Dipartimento di Scienze Biomediche e Clinche L. Sacco, Milan, Italy
5
School of Medicine, University of the Witwatersrand, Johannesburg, South Africa
✉
Contact author: Amedeo F Capetti, 1 st Division of Infectious Diseases, ‘Luigi Sacco’ University Hospital, Pavillon 56, floor 2, Via Giovanni Battista Grassi, 74, 20157, Milano, Italy. Tel.: +3934784436579; fax +390239042568; email: amedeo.capetti@unimi.it
Received 2021 Feb 21.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
PMCID: PMC7989538 PMID: 33693610